Burkitt Lymphoma
📧 Sign up to get email alerts when something new happens for Burkitt Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma [Phase 1]
This Phase 1 trial evaluated the Hsp90 inhibitor tanespimycin (17-AAG) in patients with advanced epithelial cancers, malignant lymphomas, or…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating bevacizumab in patients with various non-Hodgkin lymphomas has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas [Phase 1]
Phase 1 clinical trial evaluating 17-DMAG (alvespimycin), an HSP90 inhibitor, in patients with metastatic or unresectable solid tumors or ly…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder [Phase 1, Phase 2]
A Phase 1/2 trial evaluating Yttrium-90 ibritumomab tiuxetan in combination with rituximab for post-transplant lymphoproliferative disorder …
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma [Phase 1]
An update on a Phase 1 trial of oblimersen in combination with gemcitabine for patients with advanced solid tumors or lymphoma, which has be…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial update for cilengitide in patients with advanced solid tumors or lymphoma, with the study status reported as completed.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 study evaluated oxaliplatin in patients with relapsed or refractory non-Hodgkin lymphoma across multiple subtypes and has complete…
-
CLINICAL_TRIALS research · 2013-01-17Clinical Trial Update: Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma [Phase 1]
Phase 1 trial evaluating a radiolabeled monoclonal antibody with or without peripheral stem cell transplantation in children with recurrent …
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of SB-715992 in patients with metastatic or unresectable solid tumors and various Hodgkin's and non-Hodgkin's lymphomas has be…
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: Bryostatin and Vincristine in B-Cell Malignancies [Phase 1]
Phase 1 trial evaluating Bryostatin-1 in combination with Vincristine in several recurrent or refractory B-cell malignancies; the study has …
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating the combination of gossypol, paclitaxel, and carboplatin in patients with metastatic or unresectable solid tumors, …
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function [Phase 1]
Phase 1 trial of sorafenib in patients with metastatic or unresectable solid tumors, multiple myeloma, or non-Hodgkin lymphomas; the study h…
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma [Phase 1, Phase 2]
This clinical trial update reports on MDX-010 (ipilimumab) in treating recurrent or refractory lymphoma across multiple subtypes, with the s…
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial of belinostat (PXD101) in relapsed or refractory aggressive B-cell non-Hodgkin lymphoma has completed, with results posted in …
-
CLINICAL_TRIALS trial_result · 2012-08-27Clinical Trial Update: Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation Chemotherapy [NA]
A completed randomized trial comparing Procrit (epoetin alfa) versus no Procrit in patients with acute lymphoblastic leukemia, lymphoblastic…
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Coproporphyrine Isomers and Methotrexate Elimination
This completed clinical trial update investigates coproporphyrin isomer profiles and methotrexate elimination in patients with Central Nervo…
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 clinical trial update for the CLAG-M regimen (cladribine, cytarabine, mitoxantrone, filgrastim) in relapsed acute lymphoblastic leuk…
-
CLINICAL_TRIALS research · 2009-09-15Clinical Trial Update: Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults [Phase 4]
Provides an update on a Phase 4 clinical trial evaluating intensified therapy for adults with mature B-cell acute lymphoblastic leukemia, Bu…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas [Phase 2]
Clinical trial update reporting completion of a Phase 2 pilot protocol for the treatment of Burkitt lymphoma and diffuse large B-cell lympho…
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL [Phase 2]
A Phase 2 trial of rituximab in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma (Burkitt lymphoma) has been…
-
CLINICAL_TRIALS research · 2006-09-11Clinical Trial Update: LMBA02 Protocol for Patients With a Burkitt Lymphoma [Phase 3]
This document provides an update on the LMBA02 Phase 3 clinical trial protocol for Burkitt lymphoma. The current study status is listed as U…